Literature DB >> 17629368

The terminal portion of leptospiral immunoglobulin-like protein LigA confers protective immunity against lethal infection in the hamster model of leptospirosis.

Everton F Silva1, Marco A Medeiros, Alan J A McBride, Jim Matsunaga, Gabriela S Esteves, João G R Ramos, Cleiton S Santos, Júlio Croda, Akira Homma, Odir A Dellagostin, David A Haake, Mitermayer G Reis, Albert I Ko.   

Abstract

Subunit vaccines are a potential intervention strategy against leptospirosis, which is a major public health problem in developing countries and a veterinary disease in livestock and companion animals worldwide. Leptospiral immunoglobulin-like (Lig) proteins are a family of surface-exposed determinants that have Ig-like repeat domains found in virulence factors such as intimin and invasin. We expressed fragments of the repeat domain regions of LigA and LigB from Leptospira interrogans serovar Copenhageni. Immunization of Golden Syrian hamsters with Lig fragments in Freund's adjuvant induced robust antibody responses against recombinant protein and native protein, as detected by ELISA and immunoblot, respectively. A single fragment, LigANI, which corresponds to the six carboxy-terminal Ig-like repeat domains of the LigA molecule, conferred immunoprotection against mortality (67-100%, P<0.05) in hamsters which received a lethal inoculum of L. interrogans serovar Copenhageni. However, immunization with this fragment did not confer sterilizing immunity. These findings indicate that the carboxy-terminal portion of LigA is an immunoprotective domain and may serve as a vaccine candidate for human and veterinary leptospirosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17629368      PMCID: PMC1994161          DOI: 10.1016/j.vaccine.2007.05.053

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  45 in total

Review 1.  Leptospirosis: a zoonotic disease of global importance.

Authors:  Ajay R Bharti; Jarlath E Nally; Jessica N Ricaldi; Michael A Matthias; Monica M Diaz; Michael A Lovett; Paul N Levett; Robert H Gilman; Michael R Willig; Eduardo Gotuzzo; Joseph M Vinetz
Journal:  Lancet Infect Dis       Date:  2003-12       Impact factor: 25.071

2.  Leptospiral immunoglobulin-like proteins elicit protective immunity.

Authors:  Nobuo Koizumi; Haruo Watanabe
Journal:  Vaccine       Date:  2004-03-29       Impact factor: 3.641

3.  Sporadic urban leptospirosis.

Authors:  J M Vinetz; G E Glass; C E Flexner; P Mueller; D C Kaslow
Journal:  Ann Intern Med       Date:  1996-11-15       Impact factor: 25.391

4.  Leptospirosis: current developments and trends.

Authors:  A B Thiermann
Journal:  J Am Vet Med Assoc       Date:  1984-03-15       Impact factor: 1.936

5.  Evaluation of type 1 immune response in naïve and vaccinated animals following challenge with Leptospira borgpetersenii serovar Hardjo: involvement of WC1(+) gammadelta and CD4 T cells.

Authors:  Brian M Naiman; Seth Blumerman; David Alt; Carole A Bolin; Rachel Brown; Richard Zuerner; Cynthia L Baldwin
Journal:  Infect Immun       Date:  2002-11       Impact factor: 3.441

6.  Evidence of cross-protection within Leptospira interrogans in an experimental model.

Authors:  C Sonrier; C Branger; V Michel; N Ruvoën-Clouet; J P Ganière; G André-Fontaine
Journal:  Vaccine       Date:  2000-08-15       Impact factor: 3.641

7.  Protection against Leptospira interrogans sensu lato challenge by DNA immunization with the gene encoding hemolysin-associated protein 1.

Authors:  C Branger; B Chatrenet; A Gauvrit; F Aviat; A Aubert; J M Bach; G André-Fontaine
Journal:  Infect Immun       Date:  2005-07       Impact factor: 3.441

8.  Unique physiological and pathogenic features of Leptospira interrogans revealed by whole-genome sequencing.

Authors:  Shuang-Xi Ren; Gang Fu; Xiu-Gao Jiang; Rong Zeng; You-Gang Miao; Hai Xu; Yi-Xuan Zhang; Hui Xiong; Gang Lu; Ling-Feng Lu; Hong-Quan Jiang; Jia Jia; Yue-Feng Tu; Ju-Xing Jiang; Wen-Yi Gu; Yue-Qing Zhang; Zhen Cai; Hai-Hui Sheng; Hai-Feng Yin; Yi Zhang; Gen-Feng Zhu; Ma Wan; Hong-Lei Huang; Zhen Qian; Sheng-Yue Wang; Wei Ma; Zhi-Jian Yao; Yan Shen; Bo-Qin Qiang; Qi-Chang Xia; Xiao-Kui Guo; Antoine Danchin; Isabelle Saint Girons; Ronald L Somerville; Yu-Mei Wen; Man-Hua Shi; Zhu Chen; Jian-Guo Xu; Guo-Ping Zhao
Journal:  Nature       Date:  2003-04-24       Impact factor: 49.962

9.  Pathogenic Leptospira species express surface-exposed proteins belonging to the bacterial immunoglobulin superfamily.

Authors:  James Matsunaga; Michele A Barocchi; Julio Croda; Tracy A Young; Yolanda Sanchez; Isadora Siqueira; Carole A Bolin; Mitermayer G Reis; Lee W Riley; David A Haake; Albert I Ko
Journal:  Mol Microbiol       Date:  2003-08       Impact factor: 3.501

10.  THE PROPHYLAXIS OF WEIL'S DISEASE (SPIROCHAETOSIS ICTEROHAEMORRHAGICA).

Authors:  Y Ido; R Hoki; H Ito; H Wani
Journal:  J Exp Med       Date:  1916-11-01       Impact factor: 14.307

View more
  69 in total

1.  Subunit approach to evaluation of the immune protective potential of leptospiral antigens.

Authors:  Samuel R Félix; Daiane D Hartwig; Ana Paula C Argondizzo; Éverton F Silva; Fabiana K Seixas; Amilton C P Seixas Neto; Marco A Medeiros; Walter Lilenbaum; Odir A Dellagostin
Journal:  Clin Vaccine Immunol       Date:  2011-10-26

Review 2.  Leptospira as an emerging pathogen: a review of its biology, pathogenesis and host immune responses.

Authors:  Karen V Evangelista; Jenifer Coburn
Journal:  Future Microbiol       Date:  2010-09       Impact factor: 3.165

3.  Characterization of virulence of Leptospira isolates in a hamster model.

Authors:  Everton F Silva; Cleiton S Santos; Daniel A Athanazio; Núbia Seyffert; Fabiana K Seixas; Gustavo M Cerqueira; Michel Q Fagundes; Claudiomar S Brod; Mitermayer G Reis; Odir A Dellagostin; Albert I Ko
Journal:  Vaccine       Date:  2008-05-27       Impact factor: 3.641

4.  Highly virulent Leptospira borgpetersenii strain characterized in the hamster model.

Authors:  Juliana Alcoforado Diniz; Samuel Rodrigues Félix; Josiane Bonel-Raposo; Amilton Clair Pinto Seixas Neto; Flávia Aleixo Vasconcellos; André Alex Grassmann; Odir Antônio Dellagostin; José Antonio Guimarães Aleixo; Everton Fagonde da Silva
Journal:  Am J Trop Med Hyg       Date:  2011-08       Impact factor: 2.345

Review 5.  Leptospira: the dawn of the molecular genetics era for an emerging zoonotic pathogen.

Authors:  Albert I Ko; Cyrille Goarant; Mathieu Picardeau
Journal:  Nat Rev Microbiol       Date:  2009-10       Impact factor: 60.633

6.  Targeted mutagenesis in pathogenic Leptospira species: disruption of the LigB gene does not affect virulence in animal models of leptospirosis.

Authors:  Julio Croda; Claudio Pereira Figueira; Elsio A Wunder; Cleiton S Santos; Mitermayer G Reis; Albert I Ko; Mathieu Picardeau
Journal:  Infect Immun       Date:  2008-09-22       Impact factor: 3.441

7.  Characterization of the immunogenic and antigenic potential of putative lipoproteins from Leptospira interrogans.

Authors:  Daiane D Hartwig; Fabiana K Seixas; Gustavo M Cerqueira; Alan J A McBride; Odir A Dellagostin
Journal:  Curr Microbiol       Date:  2011-01-11       Impact factor: 2.188

8.  The Miller Hypothesis.

Authors:  David A Haake
Journal:  For Immunopathol Dis Therap       Date:  2016

9.  A conserved region of leptospiral immunoglobulin-like A and B proteins as a DNA vaccine elicits a prophylactic immune response against leptospirosis.

Authors:  Karine M Forster; Daiane D Hartwig; Fabiana K Seixas; Kátia L Bacelo; Marta Amaral; Cláudia P Hartleben; Odir A Dellagostin
Journal:  Clin Vaccine Immunol       Date:  2013-03-13

10.  Differential cytokine gene expression according to outcome in a hamster model of leptospirosis.

Authors:  Frédérique Vernel-Pauillac; Cyrille Goarant
Journal:  PLoS Negl Trop Dis       Date:  2010-01-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.